Governance
Investors

Innovating targeting

Philogen is a Swiss-Italian biotechnology company, founded in 1996 and listed on the Italian Stock Exchange, with a mission to innovate the treatment of cancer and other serious conditions.

Innovating targeting

Philogen is a Swiss-Italian biotechnology company, founded in 1996 and listed on the Italian Stock Exchange, with a mission to innovate the treatment of cancer and other serious conditions

 

Apr 17 2026
, ,

Philogen to attend AACR 2026 in San Diego, 17-22 April 2026

Dr. Matilde Bocci is presenting a poster entitled "FAP-targeting Small molecule-immunostimulator conjugate bearing a novel TLR7 agonist payload induces tumor...
Apr 17 2026
, ,

Philogen to attend EADO 2026, 23-25 April 2026

Prof. Thomas Eigentler will give a talk entitled "Intralesional L19IL2/L19TNF in high-risk lacSCC patients: results from the Phase II DUNCAN Trial Exploratory Cohort"....
Apr 17 2026
, ,

Philogen to attend the Society of Nuclear Medicine and Molecular Imaging (SNMM) annual meeting on May 30 – June 2, 2026

Prof. Philipp Backhaus will give a presentation on “Dynamics, Pharmacokinetics, and Dosimetry of First-in-Human [68Ga]Ga-OncoACP3-DOTA PET and first experience with...
Apr 17 2026
, ,

Philogen to attend the 74th American Society Mass Spectrometry annual conference in San Diego, May 31 – June 4 2026

Dr. Ettore Gilardoni will present a poster entitled "Mass Spectrometry–Based Atlas of the Blood-Accessible Surface Proteome in Syngeneic Brain Tumor Models". Follow the...
Apr 08 2026
, ,

Avviso di pubblicazione della documentazione relativa all’Assemblea degli Azionisti convocata per il 29 aprile 2026

more details
Mar 30 2026
, ,

Avviso di pubblicazione della documentazione relativa all’Assemblea degli Azionisti convocata per il 29 aprile 2026

more details
Mar 30 2026
, , ,

Philogen is pleased to invite you to an upcoming webinar on March 30, 2026, at 15:00 GMT | 16:00 CET

During the session, our management team will provide an update on the latest scientific and financial results. To register, please click on the link or contact us at...
Mar 27 2026
, ,

Il Consiglio di Amministrazione approva il progetto di bilancio di esercizio e il bilancio consolidato al 31 dicembre 2025 (Price sensitive)

more details
Mar 27 2026
, ,

The Board of Directors approves the draft financial statements and the consolidated financial statements as of december 31st, 2025 (courtesy translation) (Price sensitive)

more details
Nov 28 2025
, ,

2026 Swiss Chemical Society (SCS) Industrial Science Award for Samuele Cazzamalli, Head of Research at Philochem

Dr. Samuele Cazzamalli, Head of Research at Philochem, will be awarded the Industrial Science Award 2026 from the Swiss Chemical Society. His research has focused on...

OUR SCIENCES

Learn about our strategy

PIPELINE

Learn more about our pipeline

WORK WITH US

Look at open positions